This inventor holds 1 USPTO granted patent. Top assignee: Vetoquinol S.a.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Innovations by Claude Gaillard: A Look at His Contributions
Introduction
Claude Gaillard is an inventive mind based in Lyngby, Denmark. He has made significant strides in the field of therapeutic compositions, particularly with his patented innovation that targets the buccal and nasal mucous membranes. Gaillard's contributions exemplify the intersection of science and healthcare, reflecting his commitment to improving medical applications.
Latest Patents
Claude Gaillard holds a patent for a solid mucoadhesive therapeutic or hygienic composition designed for both human and veterinary use. This innovative formulation contains a carefully balanced mixture of ingredients: 15 to 25% by weight of a cellulosic ether that is gelifiable in the presence of aqueous liquids, 10 to 15% of either a homopolymer or copolymer of acrylic acid, a physiologically acceptable salt, 30 to 45% of gelatin, as well as one or multiple therapeutic or hygienic active constituents. The specificity of the cellulosic ether is noteworthy, as it is preferably a C1-C4 alkyl or hydroxyalkyl ether of cellulose.
Career Highlights
Claude Gaillard is currently affiliated with Vetoquinol S.A., a company renowned for its dedication to animal health and well-being. His role therein is marked by his expertise in developing new therapeutic solutions, cementing his place in the industry as a valuable team member and innovator.
Collaborations
Throughout his career, Gaillard has collaborated with notable coworkers such as Yves R Jacques and Pierre Buri. Their teamwork has undoubtedly contributed to the innovative outcomes achieved in their projects, enhancing the effectiveness of therapeutic applications.
Conclusion
Claude Gaillard's inventive prowess and dedication to developing novel therapeutic compositions have marked him as a significant figure in the realm of medical innovations. His patent reflects a deep understanding of material science and its applications in healthcare, promising advancements that could benefit both human and veterinary medicine. The collaborative efforts within his team further emphasize the importance of teamwork in driving innovations forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile